Search

The UK is to back up a review of science and innovation policy by former science minister David Sainsbury with £1 billion over the next three years to boost business innovation and technology development.

Biotech and pharma companies have overtaken the technology sector in the European Commission’s annual scoreboard of R&D investment for the first time.

With the French Senate ratifying the London Agreement on patent translation, technology companies can look to a much cheaper future.

Flagship venture capitalist David Berry takes a hands-on approach to finding and nurturing emerging ideas and companies in life sciences and clean energy.

A major survey shows confidence holding steady as early-stage funding eases slightly – and the relationship with big pharma improves.

PepsiCo’s $5.2 million donation to look at lifestyle and chronic disease looks like an act of the archest cynicism. But someone needs to do something, says Nuala Moran.

New findings strengthen concerns that the European Clinical Trials Directive has hampered academic clinical research.

The European Investment Bank and the European Commission have announced the introduction of the Risk Sharing Finance Facility to provide additional support to R&D and innovation projects in Europe.

The scientists’ organisation Euroscience has welcomed the European Commission’s Green paper on the European Research Area – but raised concerns about aspects of the consultative procedures.

The UK Conservative Party has joined the tidal wave of opinion arguing that the European Union needs to use its public procurement budget to drive innovation.

Nordforsk, the funding agency of the Nordic Council of Ministers, has funded the coordination of a network on biomedical imaging.

Plans to create a European Research Area put too much stress on research and not enough on innovation, says the Eureka secretariat.

The European Parliament gave its formal blessing to the launch of a new pan-European technology institute next year – but insisted that it include “innovation” in the title.

The technology transfer arm of Imperial College London reported rapid growth in its investment portfolio in its first full year as a publicly traded company.

Today France Biotech celebrates its tenth birthday at the Eurobio Show in Lille. And the picture has never been rosier.

The European Commission has laid out a new strategy for financing the parlous Galileo global positioning system and getting the European Institute of Technology off the ground.